Abstract
Real-Life Survival Data after Triple-Exposure to Proteasome Inhibitors (PI), Immunomodulators (IMID) and Anti-CD38 in Multiple Myeloma Patients in the Emmy Cohort
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have